ArticleBMC psychiatry2025
Trait- versus state- grey matter volume alterations in premenstrual dysphoric disorder.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Impairment of Executive Functions in Premenstrual Syndrome: State or Trait?Biological psychiatry global open science · 2026Article
- Personality and cortical architecture in premenstrual dysphoric disorder.Archives of women's mental health · 2026Article
- White Matter Regional Volumes in Relation to Menstrual Cycle Phase and Premenstrual Dysphoric Disorder.Biological psychiatry global open science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPremenstrual dysphoric disorder (PMDD) is characterized by symptoms of irritability, affective lability, anxiety, and depression, which occur only in the luteal phase of ovulatory menstrual cycles. This offers an ideal model to assess the neural correlates of the on and off switch of mood symptoms. Recently, we highlighted differences in grey matter volume between individuals with PMDD and healthy controls during the luteal phase, depicting smaller volumes in those diagnosed with the condition. However, it is unknown whether such alterations represent state-like changes specific to the symptomatic phase, or trait-like characteristics.
methodsHere, 28 patients with PMDD and 26 controls underwent anatomical magnetic resonance imaging during the mid-follicular and the late-luteal phases of the menstrual cycle. For each time point, we assessed grey matter volumes over the whole brain using voxel-based morphometry.
resultsWe found no group-by-phase interaction effect on grey matter volumes, but a main effect of group across menstrual cycle phases, suggesting trait rather than state structural markers of PMDD. Patients displayed smaller volumes compared to controls, primarily in the cerebellum and cuneus, and at a trend-level in ventral occipito-temporal, parietal, paracentral and orbitofrontal areas, as well as the putamen (Cohen’s d range: 0.4–1.1).
conclusionsThese findings suggest that the differences in grey matter volumes found in PMDD are stable across the menstrual cycle and could represent trait-like, vulnerability markers of PMDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.